Ask AI
ProCE Banner Activity

Transforming MDD Care: A Comprehensive Look at Adjunctive Treatment Options

Slideset

This downloadable slideset summarizes MDD care plans by integrating practical augmentation/switching criteria, optimizing augmentation dosing and monitoring protocols, and addressing adherence barriers via case studies highlighting comorbidity management and patient-centered communication.

Released: December 05, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AbbVie Inc. and Intra-Cellular Therapies, Inc.

AbbVie Inc.

Intra-Cellular Therapies, Inc.

Target Audience

This activity is intended for healthcare professionals caring for patients with major depressive disorder, including physicians (psychiatrists and family medicine/primary care), nurse practitioners, physician associates, registered nurses, pharmacists, and psychologists.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify key criteria for deciding when to switch or augment medications in MDD according to best practice guidelines

  • Analyze the latest evidence supporting the use of antipsychotics in treating MDD

  • Distinguish between augmentation options in MDD based on their pharmacologic profiles

  • Develop a personalized treatment plan for MDD, tailored to individual patient needs and medication attributes